Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
In 2020, as the world faces another new virus stoking fear and uncertainty, San Francisco may be uniquely up to the challenge. Strong ties between UCSF, local government agencies and community groups, forged in the fire of the AIDS epidemic, and a deep bench of infectious disease expertise, has helped the city flatten the curve and better understand this new disease.
Patients were hypothetically willing to increase wait time and travel distance—and accept significant reduction in medication—in order to access a healthcare provider with a nice attitude, according to a new survey.
A staggering 64,000 people in the United States died in 2016 from drug overdoses – and a study led by UCSF’s Daniel Ciccarone is aiming to get at the heart of of the problem, including by interviewing opioid users.
The journey from discovering and developing effective, precise medications to using them correctly and safely in patients is hardly fast and easy. Nor is it a straight shot. Scientists in the UCSF School of Pharmacy are challenging the status quo every step of the way.
Since her days as a physician trainee, Diane Havlir, now Chief of the HIV, Infectious Diseases and Global Medicine Division at UCSF, has continued the crusade to end AIDS. She spoke about global HIV elimination at Fortune’s Brainstorm Health Conference in San Diego on May 2.
Ward 86 at Zuckerberg San Francisco General Hospital and Trauma Center has launched Golden Compass, a new program to meet the health needs of the increasing population of HIV patients who are growing older.
HIV-positive people and people with type 2 diabetes, who received healthy food and snacks for six months were more likely to adhere to their medication regimens, were less depressed and less likely to make trade-offs between food and healthcare.
People with bipolar disorder, schizophrenia and major depression with psychosis may be up to 15 more likely than the general population to be HIV positive, but are only marginally more likely to be tested for the virus.